ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Capsida Biotherapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Capsida Biotherapeutics, INC. (Capsida Biotherapeutics, INC. 401(k) Plan · EIN 83-4673583 · PN 001): $5.25M net assets, 116 active participants, and $10.96 per $10,000 (10.96 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorCapsida Biotherapeutics, INC.
Filing IdentifierCapsida Biotherapeutics, INC. 401(k) Plan · EIN 83-4673583 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$1M-$5M
Plan Net Assets (2024)$5.25M
Active Participants116
Direct Admin Fee Rate$10.96 per $10,000 (10.96 bps)
Cohort Peer Median$63.02 per $10,000 (63.02 bps)
Primary Recordkeeper / ProviderUnbundled / Direct Trust
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($12,342, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI